These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20939070)

  • 1. A pilot open-label trial of zonisamide in Unverricht-Lundborg disease.
    Italiano D; Pezzella M; Coppola A; Magaudda A; Ferlazzo E; Bramanti P; Striano S; Zara F; Striano P
    Mov Disord; 2011 Feb; 26(2):341-3. PubMed ID: 20939070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brivaracetam in Unverricht-Lundborg disease (EPM1): Results from two randomized, double-blind, placebo-controlled studies.
    Kälviäinen R; Genton P; Andermann E; Andermann F; Magaudda A; Frucht SJ; Schlit AF; Gerard D; de la Loge C; von Rosenstiel P
    Epilepsia; 2016 Feb; 57(2):210-21. PubMed ID: 26666500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations.
    Magaudda A; Gelisse P; Genton P
    Epilepsia; 2004 Jun; 45(6):678-81. PubMed ID: 15144434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical picture of EPM1-Unverricht-Lundborg disease.
    Kälviäinen R; Khyuppenen J; Koskenkorva P; Eriksson K; Vanninen R; Mervaala E
    Epilepsia; 2008 Apr; 49(4):549-56. PubMed ID: 18325013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of efficacy and potential aggravation of myoclonus with lamotrigine in Unverricht-Lundborg disease.
    Genton P; Gelisse P; Crespel A
    Epilepsia; 2006 Dec; 47(12):2083-5. PubMed ID: 17201707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unverricht-Lundborg progressive myoclonus epilepsy in Oman.
    Santoshkumar B; Turnbull J; Minassian BA
    Pediatr Neurol; 2008 Apr; 38(4):252-5. PubMed ID: 18358403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures.
    Sackellares JC; Ramsay RE; Wilder BJ; Browne TR; Shellenberger MK
    Epilepsia; 2004 Jun; 45(6):610-7. PubMed ID: 15144425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severer phenotype in Unverricht-Lundborg disease (EPM1) patients compound heterozygous for the dodecamer repeat expansion and the c.202C>T mutation in the CSTB gene.
    Koskenkorva P; Hyppönen J; Aikiä M; Mervaala E; Kiviranta T; Eriksson K; Lehesjoki AE; Vanninen R; Kälviäinen R
    Neurodegener Dis; 2011; 8(6):515-22. PubMed ID: 21757863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol.
    Morita S; Miwa H; Kondo T
    Parkinsonism Relat Disord; 2005 Mar; 11(2):101-3. PubMed ID: 15734668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Movement-related desynchronization-synchronization (ERD/ERS) in patients with Unverricht-Lundborg disease.
    Visani E; Agazzi P; Canafoglia L; Panzica F; Ciano C; Scaioli V; Avanzini G; Franceschetti S
    Neuroimage; 2006 Oct; 33(1):161-8. PubMed ID: 16904345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refining the phenotype of Unverricht-Lundborg disease (EPM1): a population-wide Finnish study.
    Hyppönen J; Äikiä M; Joensuu T; Julkunen P; Danner N; Koskenkorva P; Vanninen R; Lehesjoki AE; Mervaala E; Kälviäinen R
    Neurology; 2015 Apr; 84(15):1529-36. PubMed ID: 25770194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor cortex and thalamic atrophy in Unverricht-Lundborg disease: voxel-based morphometric study.
    Koskenkorva P; Khyuppenen J; Niskanen E; Könönen M; Bendel P; Mervaala E; Lehesjoki AE; Kälviäinen R; Vanninen R
    Neurology; 2009 Aug; 73(8):606-11. PubMed ID: 19704079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered cortical inhibition in Unverricht-Lundborg type progressive myoclonus epilepsy (EPM1).
    Danner N; Julkunen P; Khyuppenen J; Hukkanen T; Könönen M; Säisänen L; Koskenkorva P; Vanninen R; Lehesjoki AE; Kälviäinen R; Mervaala E
    Epilepsy Res; 2009 Jul; 85(1):81-8. PubMed ID: 19321308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
    Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study.
    Coppola G; Grosso S; Verrotti A; Parisi P; Luchetti A; Franzoni E; Mangano S; Pelliccia A; Operto FF; Iannetti P; Curatolo P; Balestri P; Pascotto A
    Epilepsy Res; 2009 Feb; 83(2-3):112-6. PubMed ID: 19081227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unverricht-Lundborg disease (EPM1).
    Genton P
    Epilepsia; 2010 Feb; 51 Suppl 1():37-9. PubMed ID: 20331711
    [No Abstract]   [Full Text] [Related]  

  • 18. A prospective audit of adjunctive zonisamide in an everyday clinical setting.
    Stephen LJ; Kelly K; Wilson EA; Parker P; Brodie MJ
    Epilepsy Behav; 2010 Apr; 17(4):455-60. PubMed ID: 20207201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.
    Zesiewicz TA; Ward CL; Hauser RA; Sanchez-Ramos J; Staffetti JF; Sullivan KL
    Mov Disord; 2007 Jan; 22(2):279-82. PubMed ID: 17149715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiepileptic drug intervention decouples electroencephalogram (EEG) signals: a case study in Unverricht-Lundborg Disease.
    Liu CC; Xanthopoulos P; Chaovalitwongse W; Pardalos PM; Uthman BM
    Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():2108-11. PubMed ID: 19163112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.